IE 11 is not supported. For an optimal experience visit our site on another browser.

Johnson & Johnson vaccine: What to know about efficacy


NBC News medical contributors Dr. Vin Gupta and Dr. Natalie Azar join the 3rd hour of TODAY to discuss the Johnson & Johnson’s one-shot COVID-19 vaccine. Azar notes that its overall efficacy was 66% for prevention of moderate to severe disease and in the U.S. that increased to 72%. ****Dr. Natalie Azar's comments have been edited to clarify what she said about the number of vaccines that Johnson & Johnson has pledged to make available.**